On ECHEMI
Home > Drugs > Levamisole Hydrochloride Tablets

Levamisole Hydrochloride Tablets

Function and Efficacy

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, causing continuous contraction of the muscles and paralysis; the drug's cholinergic effect is beneficial to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune excitation functions

Ingredients

The main ingredient is levamisole hydrochloride, which is the levorotatory form of tetramisole.

Name Description Content CAS NO. Manufacturer
Levamisole hydrochlorideIngredients

It is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune excitation functions.

More
16595-80-5 7

Appearance

This product is white tablet or sugar-coated tablet.

Indication

It has good efficacy against ascaris, hookworm, pinworm and strongyloidiasis. Since the single dose of this product has a high efficacy, it is suitable for group treatment. It is more active than ethopropazine against adult worms and microfilariae of Bancroftian filariasis, Malayan Brugia and Onchocerca volvulus, but the long-term efficacy is poor.

Usage and Dosage

1. For deworming: Oral administration, 1.5-2.5 mg/kg for adults, taken on an empty stomach or before bedtime, 2-3 mg/kg for children. 2. For deworming: Oral administration, 1.5-2.5 mg/kg, once a night, for 3 consecutive days. 3. For the treatment of filariasis: 4-6 mg/kg, taken in 2-3 doses, for 3 consecutive days.

Adverse Reactions

Generally mild. Symptoms include nausea, vomiting, abdominal pain, etc. A few may experience taste disorders, fatigue, dizziness, headache, joint pain, confusion, insomnia, fever, flu-like symptoms, low blood pressure, vasculitis, rash, photosensitivity dermatitis, etc. Proteinuria is occasionally seen. Some may have granulocytopenia and thrombocytopenia. A few may even have agranulocytosis (often reversible), which often occurs in patients with rheumatism or tumors. In addition, it can cause immediate and Arthus allergic reactions, which may be atopic reactions caused by stimulating T cells. Individual cases may experience ataxia, paresthesia, or blurred vision.

Precautions

It is contraindicated in patients with impaired liver and kidney function, active hepatitis, early pregnancy, or pre-existing schistosomiasis.

Special Population Medication

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

Drug Interactions

(1) It can be used in combination with pyrantel to treat severe hookworm infections and improve the effectiveness of expelling American hookworms. (2) It can be used in combination with thiabendazole to treat mixed infections of intestinal nematodes. (3) It can be used sequentially with diethylcarbamazine citrate to treat filarial infections. (4) It should not be used in combination with tetrachloroethylene to avoid increasing its toxicity.

Storage

Seal and keep dry.

Packaging Specification

25mg

Validity Period

24 months

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.